Skip to main content
FinSpry Logo
FinSpry
AVTX logo
AVTX
(NASDAQ)
Avalo Therapeutics, Inc.
$17.76-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Avalo Therapeutics (AVTX) Stock Price & Financial Analysis

Avalo Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.07 - $17.83
52-Week High$20.72
52-Week Low$3.39
Open$16.39
Volume1.11M
Average Volume (3M)1.11M
Market Cap248.65M
Shares Outstanding14.00M
Price to Sales (P/S)1217.75
Price to Book (P/B)2.55
EV/EBITDA-3.14
Revenue (TTM)192.00K
Net Income (TTM)-99.88M
EPS (TTM)$-7.13
Profit Margin-52019.79%
Operating Margin-34632.29%
Return on Equity (ROE)-109.10%
Debt to Equity0.01
50-Day MA$15.50
200-Day MA$13.24
52-Week Change143.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Avalo Therapeutics

What is the current stock price for AVTX?

As of the latest trading session, AVTX stock trades at $17.76. The 52-week range is $3.39–$20.72, with a day range of $16.07–$17.82.

What is the P/E ratio for AVTX?

The P/E ratio (Price-to-Earnings) for AVTX is shown in the Key Statistics section. This valuation metric helps compare Avalo Therapeutics, Inc. to industry peers.

Does AVTX pay dividends?

Avalo Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AVTX?

Based on 3 analysts, the consensus for AVTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AVTX?

Avalo Therapeutics's market capitalization is $248.6M, classifying it as a micro-cap company. Avalo Therapeutics operates in the Healthcare sector within the Biotechnology industry.